Dovato (Lamivudine, Dolutegravir Sodium)

Dovato is a combination medication containing Lamivudine and Dolutegravir Sodium, used for HIV treatment. This oral medication is designed to help manage HIV infection by reducing viral load.

Dovato is primarily used in the treatment of HIV-1 infection in adults. It combines two active ingredients, Lamivudine and Dolutegravir Sodium, which work together to reduce the amount of HIV in the body. This medication is often prescribed as part of a comprehensive HIV treatment plan, aiming to improve immune function and reduce the risk of HIV-related complications.

Common effects of Dovato may include headache, diarrhea, and nausea. Some individuals might experience fatigue or dizziness. These effects vary among users and are not experienced by everyone taking the medication.

Dovato should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Dovato may interact with certain medications, including some antacids, antibiotics, and antifungal drugs. It is crucial to discuss all current medications with a healthcare provider to ensure safe and effective use. Alcohol consumption should be moderated while taking Dovato.